<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03910000_2</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P68871</UniProt_ID>
  <Seq_Length>147</Seq_Length>
  <Molecule_Weight>15998</Molecule_Weight>
  <KEGG_ID>hsa:3043</KEGG_ID>
  <Orthology_ID>K13823</Orthology_ID>
  <EBI_ID>EBI-715554</EBI_ID>
  <Function_Summary>Involved in oxygen transport from the lung to the various peripheral tissues.LVV-hemorphin-7 potentiates the activity of bradykinin, causing a decrease in blood pressure.</Function_Summary>
  <Pfam_ID>PF00042:Globin</Pfam_ID>
  <Allosteric_Activator_Count>14</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>64</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>77</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Hemoglobin subunit beta</Alias>
      <Alias>Beta globin chain</Alias>
      <Alias>Hemoglobin beta chain</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with hemoglobin, an oxygen carrying, conjugated protein containing four heme groups and globin.</Detail>
      <Keyword>Hemoglobin binding</Keyword>
      <Ontology_ID>GO:0030492</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Enables the directed movement of oxygen into, out of or within a cell, or between cells.</Detail>
      <Keyword>Oxygen transporter activity</Keyword>
      <Ontology_ID>GO:0005344</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring.</Detail>
      <Keyword>Heme binding</Keyword>
      <Ontology_ID>GO:0020037</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with oxygen (O2).</Detail>
      <Keyword>Oxygen binding</Keyword>
      <Ontology_ID>GO:0019825</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>91</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>82</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>39</Position>
      <Original>Thr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>40</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>102</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>22</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>122</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>11</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>33</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>79</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>96</Position>
      <Original>Lys</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>125</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>80</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>105</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>25</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>47</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>61</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>84</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>28</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>7</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>33</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>38</Position>
      <Original>Trp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>87</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>137</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>74</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>121</Position>
      <Original>Lys</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>130</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>144</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>63</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>66</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>102</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>116</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>3</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>128</Position>
      <Original>Gln</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>100</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>101</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>118</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>118</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>57</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>48</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>140</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>101</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>7</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>99</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>66</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>2</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>74</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>75</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>15</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>78</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>96</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>36</Position>
      <Original>Tyr</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>103</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>9</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>93</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>91</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>143</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>29</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>29</Position>
      <Original>Leu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>147</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>92</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>22</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>23</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>95</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>128</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>88</Position>
      <Original>Thr</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>62</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>122</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>68</Position>
      <Original>Val</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>37</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>8</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>18</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>3</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>89</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>63</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>42</Position>
      <Original>Phe</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>94</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>133</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>24</Position>
      <Original>Val</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>134</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>3</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>117</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>103</Position>
      <Original>Asn</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>68</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>146</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>121</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>121</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>38</Position>
      <Original>Trp</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>81</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>72</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>88</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>117</Position>
      <Original>His</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>82</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>51</Position>
      <Original>Thr</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>8</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>125</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>3</Position>
      <Original>His</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>132</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>89</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>97</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>145</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>6</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>133</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>125</Position>
      <Original>Pro</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>56</Position>
      <Original>Met</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>140</Position>
      <Original>Asn</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>9</Position>
      <Original>Lys</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>98</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>46</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>85</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>110</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>129</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>124</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>18</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>120</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>45</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>40</Position>
      <Original>Gln</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>25</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>48</Position>
      <Original>Asp</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>98</Position>
      <Original>His</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>64</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>26</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>75</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>77</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>22</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>43</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>32</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>71</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>118</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>109</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>84</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>7</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>141</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>50</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>135</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>16</Position>
      <Original>Trp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>70</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>147</Position>
      <Original>His</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>102</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>140</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>22</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>83</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>20</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>23</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>16</Position>
      <Original>Trp</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>95</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>38</Position>
      <Original>Trp</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>68</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>127</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>23</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>95</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>104</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>53</Position>
      <Original>Asp</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>147</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>93</Position>
      <Original>His</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>11</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>23</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>55</Position>
      <Original>Val</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>26</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>93</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>35</Position>
      <Original>Val</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>98</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>20</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>27</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>113</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>76</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>31</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>62</Position>
      <Original>Lys</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>35</Position>
      <Original>Val</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>136</Position>
      <Original>Ala</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>44</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>88</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>17</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>59</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>49</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>144</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>115</Position>
      <Original>Leu</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>127</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>23</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>70</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>139</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>35</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>93</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>53</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>98</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>113</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>60</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>147</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>58</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>112</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>105</Position>
      <Original>Arg</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>132</Position>
      <Original>Gln</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>144</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>146</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>76</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>144</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>140</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>108</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>20</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>17</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>18</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>97</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>27</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>68</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>10</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>30</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>113</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>131</Position>
      <Original>Tyr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>28</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>102</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>78</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>21</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>28</Position>
      <Original>Ala</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>7</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>37</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>67</Position>
      <Original>Lys</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>9</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>142</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>122</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>14</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>24</Position>
      <Original>Val</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>115</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>43</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>69</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>130</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>83</Position>
      <Original>Lys</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>12</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>82</Position>
      <Original>Leu</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>122</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>12</Position>
      <Original>Val</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>52</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>19</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>131</Position>
      <Original>Tyr</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>74</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>132</Position>
      <Original>Gln</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>24</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>92</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>15</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>116</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>48</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>62</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>90</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>69</Position>
      <Original>Leu</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>25</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>70</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>90</Position>
      <Original>Ser</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>136</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>37</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>132</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>40</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>122</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>127</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>141</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>78</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>141</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>66</Position>
      <Original>Lys</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>111</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.</Detail>
      <Keyword>Regulation of blood pressure</Keyword>
      <Ontology_ID>GO:0008217</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of nitric oxide, nitrogen monoxide, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Nitric oxide transport</Keyword>
      <Ontology_ID>GO:0030185</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of hydrogen peroxide (H2O2).</Detail>
      <Keyword>Hydrogen peroxide catabolic process</Keyword>
      <Ontology_ID>GO:0042744</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Transport</Keyword>
      <Ontology_ID>GO:0006810</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.</Detail>
      <Keyword>Positive regulation of cell death</Keyword>
      <Ontology_ID>GO:0010942</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.</Detail>
      <Keyword>Blood coagulation</Keyword>
      <Ontology_ID>GO:0007596</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the size of blood vessels.</Detail>
      <Keyword>Regulation of blood vessel size</Keyword>
      <Ontology_ID>GO:0050880</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers that are not all identical. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.</Detail>
      <Keyword>Protein heterooligomerization</Keyword>
      <Ontology_ID>GO:0051291</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of oxygen (O2) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Oxygen transport</Keyword>
      <Ontology_ID>GO:0015671</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.</Detail>
      <Keyword>Positive regulation of nitric oxide biosynthetic process</Keyword>
      <Ontology_ID>GO:0045429</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A renal system process in which water, ions, and glucose are taken up from the collecting ducts and proximal and distal loops of the nephron.</Detail>
      <Keyword>Renal absorption</Keyword>
      <Ontology_ID>GO:0070293</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>94</Position>
      <PTM_Type>S-nitrosocysteine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-acetylalanine</PTM_Type>
    </PTM>
    <PTM>
      <Position>131</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-pyruvate 2-iminyl-valine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MVHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENFRLLGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH</Protein_Seq>
    <DNA_Seq>ATGGTNCAYYTNACNCCNGTGGAGAAGTCYGCYGTNACNGCNCTNTGGGGYAAGGTNAAYGTGGATGAAGYYGGYGGYGAGGCCCTGGGCAGNCTGCTNGTGGTCTACCCTTGGACCCAGAGGTTCTTNGANTCNTTYGGGGATCTGNNNACNCCNGANGCAGTTATGGGCAACCCTAAGGTGAAGGCTCATGGCAAGAAAGTGCTCGGTGCCTTTAGTGATGGCCTGGCTCACCTGGACAACCTCAAGGGCACCTTTGCCACACTGAGTGAGCTGCACTGTGACAAGCTNCAYGTGGATCCTGAGAACTTCAGGCTNCTNGGCAACGTGYTNGTCTGYGTGCTGGCCCATCACTTTGGCAAAGAATTCACCCCACCAGTGCANGCNGCCTATCAGAAAGTGGTNGCTGGTGTNGCTAATGCCCTGGCCCACAAGTATCACTAAGCTNGCYTTYTTGYTGTCCAATTT</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Red blood cells</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <Gene>
    <Gene_Name>HBB</Gene_Name>
    <Gene_ID>3043</Gene_ID>
    <Genbank_ACCN>NM_000518</Genbank_ACCN>
    <Protein_ACCN>NP_000509</Protein_ACCN>
    <HGNC_ID>4827</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/3043</Gene_URL>
    <UCSC_ID>uc001mae.1</UCSC_ID>
    <EMBL_ID>ENSG00000244734</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P69905</Uniprot_ID>
      <Gene_Name>HBA2</Gene_Name>
      <EBI_ID>EBI-714680</EBI_ID>
      <PPI_EBI_URL>EBI-715554,EBI-714680</PPI_EBI_URL>
      <Experiment_Number>19</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Erythremias, Beta-</Disease_Name>
      <Disease_Detail>Erythremias</Disease_Detail>
      <Disease_DB>ERY027</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/erythremias_beta?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sickle Cell - Hemoglobin E Disease</Disease_Name>
      <Disease_Detail>Sickle Cell Anemia</Disease_Detail>
      <Disease_DB>SCK030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sickle_cell_hemoglobin_e_disease?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Methemoglobinemias, Beta-</Disease_Name>
      <Disease_Detail>Methemoglobinemia</Disease_Detail>
      <Disease_DB>MTH031</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/methemoglobinemias_beta?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemoglobin E - Beta-Thalassemia</Disease_Name>
      <Disease_Detail>Hemoglobin E Disease</Disease_Detail>
      <Disease_DB>HMG021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemoglobin_e_beta_thalassemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Splenic Infarction</Disease_Name>
      <Disease_Detail>Splenic Infarction</Disease_Detail>
      <Disease_DB>SPL006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/splenic_infarction?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Heinz Body Anemias</Disease_Name>
      <Disease_Detail>Heinz Body Anemia</Disease_Detail>
      <Disease_DB>HNZ004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/heinz_body_anemias?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemoglobin Lepore - Beta-Thalassemia</Disease_Name>
      <Disease_Detail>Hemoglobin Lepore - Beta-Thalassemia</Disease_Detail>
      <Disease_DB>HMG023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemoglobin_lepore_beta_thalassemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thalassemia, Hispanic Gamma-Delta-Beta</Disease_Name>
      <Disease_Detail>Thalassemia</Disease_Detail>
      <Disease_DB>THL013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thalassemia_hispanic_gamma_delta_beta?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hereditary Persistence of Fetal Hemoglobin - Sickle Cell Disease</Disease_Name>
      <Disease_Detail>Hereditary Persistence of Fetal Hemoglobin</Disease_Detail>
      <Disease_DB>HRD111</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hereditary_persistence_of_fetal_hemoglobin_sickle_cell_disease?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Heinz Body Anemia</Disease_Name>
      <Disease_Detail>Heinz Body Anemia</Disease_Detail>
      <Disease_DB>HNZ001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/heinz_body_anemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Chest Syndrome</Disease_Name>
      <Disease_Detail>Acute Chest Syndrome</Disease_Detail>
      <Disease_DB>ACT017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_chest_syndrome?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemoglobinemia</Disease_Name>
      <Disease_Detail>Hemoglobinemia</Disease_Detail>
      <Disease_DB>HMG010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemoglobinemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hereditary Persistence of Fetal Hemoglobin</Disease_Name>
      <Disease_Detail>Hereditary Persistence of Fetal Hemoglobin</Disease_Detail>
      <Disease_DB>HRD024</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hereditary_persistence_of_fetal_hemoglobin?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Autosomal Dominant Methemoglobinemia</Disease_Name>
      <Disease_Detail>Autosomal Dominant Methemoglobinemia</Disease_Detail>
      <Disease_DB>ATS088</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/autosomal_dominant_methemoglobinemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemoglobin D Disease</Disease_Name>
      <Disease_Detail>Hemoglobin D Disease</Disease_Detail>
      <Disease_DB>HMG004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemoglobin_d_disease?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Malaria</Disease_Name>
      <Disease_Detail>Malaria</Disease_Detail>
      <Disease_DB>MLR004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/malaria?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Siderosis</Disease_Name>
      <Disease_Detail>Siderosis</Disease_Detail>
      <Disease_DB>SDR002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/siderosis?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Delta-Beta Thalassemia</Disease_Name>
      <Disease_Detail>Delta-Beta Thalassemia</Disease_Detail>
      <Disease_DB>DLT009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/delta_beta_thalassemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thalassemia-Beta, Dominant Inclusion-Body</Disease_Name>
      <Disease_Detail>Thalassemia</Disease_Detail>
      <Disease_DB>THL011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thalassemia_beta_dominant_inclusion_body?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Invasive Aspergillosis</Disease_Name>
      <Disease_Detail>Invasive Aspergillosis</Disease_Detail>
      <Disease_DB>INV001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/invasive_aspergillosis?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Congenital Hemolytic Anemia</Disease_Name>
      <Disease_Detail>Congenital Hemolytic Anemia</Disease_Detail>
      <Disease_DB>CNG027</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/congenital_hemolytic_anemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>C3 Deficiency</Disease_Name>
      <Disease_Detail>C3 Deficiency</Disease_Detail>
      <Disease_DB>C3D001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/c3_deficiency?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sickle Cell Disease</Disease_Name>
      <Disease_Detail>Sickle Cell Anemia</Disease_Detail>
      <Disease_DB>SCK005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sickle_cell_disease?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Congenital Dyserythropoietic Anemia Type I</Disease_Name>
      <Disease_Detail>Congenital Dyserythropoietic Anemia Type I</Disease_Detail>
      <Disease_DB>CNG045</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/congenital_dyserythropoietic_anemia_type_i?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Alpha Thalassemia</Disease_Name>
      <Disease_Detail>Alpha Thalassemia</Disease_Detail>
      <Disease_DB>ALP006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/alpha_thalassemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hypochromic Anemia</Disease_Name>
      <Disease_Detail>Hypochromic Anemia</Disease_Detail>
      <Disease_DB>HYP054</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hypochromic_anemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Methemoglobinemia</Disease_Name>
      <Disease_Detail>Methemoglobinemia</Disease_Detail>
      <Disease_DB>MTH007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/methemoglobinemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thalassemias, Beta-</Disease_Name>
      <Disease_Detail>Thalassemia</Disease_Detail>
      <Disease_DB>THL015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thalassemias_beta?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sickle Cell - Beta-Thalassemia Disease</Disease_Name>
      <Disease_Detail>Sickle Cell Anemia</Disease_Detail>
      <Disease_DB>SCK021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sickle_cell_beta_thalassemia_disease?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemoglobin So</Disease_Name>
      <Disease_Detail>Hemoglobin So</Disease_Detail>
      <Disease_DB>HMG017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemoglobin_so?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemoglobin C Disease</Disease_Name>
      <Disease_Detail>Hemoglobin C Disease</Disease_Detail>
      <Disease_DB>HMG001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemoglobin_c_disease?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Fetal Hemoglobin Quantitative Trait Locus 1</Disease_Name>
      <Disease_Detail>Fetal Hemoglobin Quantitative Trait Locus 1</Disease_Detail>
      <Disease_DB>FTL033</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/fetal_hemoglobin_quantitative_trait_locus_1?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemoglobin Constant Spring</Disease_Name>
      <Disease_Detail>Hemoglobin Constant Spring</Disease_Detail>
      <Disease_DB>HMG012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemoglobin_constant_spring?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemoglobin S Beta-Thalassemia</Disease_Name>
      <Disease_Detail>Hemoglobin S Beta-Thalassemia</Disease_Detail>
      <Disease_DB>HMG015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemoglobin_s_beta_thalassemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Heinz Body Anemias, Beta-</Disease_Name>
      <Disease_Detail>Heinz Body Anemia</Disease_Detail>
      <Disease_DB>HNZ003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/heinz_body_anemias_beta?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemoglobin E Disease</Disease_Name>
      <Disease_Detail>Hemoglobin E Disease</Disease_Detail>
      <Disease_DB>HMG003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemoglobin_e_disease?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Beta Thalassemia</Disease_Name>
      <Disease_Detail>Beta Thalassemia</Disease_Detail>
      <Disease_DB>BTT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/beta_thalassemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sickle Cell - Hemoglobin C Disease</Disease_Name>
      <Disease_Detail>Sickle Cell Anemia</Disease_Detail>
      <Disease_DB>SCK031</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sickle_cell_hemoglobin_c_disease?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemoglobin C - Beta-Thalassemia</Disease_Name>
      <Disease_Detail>Hemoglobin C - Beta-Thalassemia</Disease_Detail>
      <Disease_DB>HMG022</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemoglobin_c_beta_thalassemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemoglobin Sd</Disease_Name>
      <Disease_Detail>Hemoglobin Sd</Disease_Detail>
      <Disease_DB>HMG016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemoglobin_sd?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemoglobinopathy</Disease_Name>
      <Disease_Detail>Hemoglobinopathy</Disease_Detail>
      <Disease_DB>HMG005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemoglobinopathy?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thalassemias, Alpha-</Disease_Name>
      <Disease_Detail>Thalassemia</Disease_Detail>
      <Disease_DB>THL016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thalassemias_alpha?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sickle Cell Anemia</Disease_Name>
      <Disease_Detail>Sickle Cell Anemia</Disease_Detail>
      <Disease_DB>SCK003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sickle_cell_anemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Trachoma</Disease_Name>
      <Disease_Detail>Trachoma</Disease_Detail>
      <Disease_DB>TRC008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/trachoma?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thalassemia</Disease_Name>
      <Disease_Detail>Thalassemia</Disease_Detail>
      <Disease_DB>THL005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thalassemia?search=HBB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sickle Cell - Hemoglobin D Disease</Disease_Name>
      <Disease_Detail>Sickle Cell Anemia</Disease_Detail>
      <Disease_DB>SCK020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sickle_cell_hemoglobin_d_disease?search=HBB#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Cyanomet hemoglobin (A-GLY-C:V1M,L29F,H58Q; B,D:V1M,L106W)</PDB_Title>
      <PDB_ID>1O1I</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1O1I</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CYANIDE ION$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
    </PDB>
    <PDB>
      <PDB_Title>NI BETA HEME HUMAN HEMOGLOBIN</PDB_Title>
      <PDB_ID>1DKE</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DKE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>Oxygen binding by alpha(Fe2+)2beta(Ni2+)2 hemoglobin crystals.</PubMed_Title>
      <Author>Bruno S, et al.</Author>
      <Journal>Protein Sci.2000 Apr;9(4):683-92.</Journal>
      <PubMed_ID>10794410</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DEOXY HEMOGLOBIN (90% RELATIVE HUMIDITY)</PDB_Title>
      <PDB_ID>1LFL</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LFL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Structures of human oxy- and deoxyhaemoglobin at different levels of humidity: variability in the T state.</PubMed_Title>
      <Author>Biswal BK, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2002 Jul;58(Pt 7):1155-61. Epub  2002 Jun 20.</Journal>
      <PubMed_ID>12077435</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A Fourth Quaternary Structure of Human Hemoglobin A at 2.18 A Resolution</PDB_Title>
      <PDB_ID>1MKO</PDB_ID>
      <Resolution>2.18</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1MKO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>The enigma of the liganded hemoglobin end state: a novel quaternary structure of human carbonmonoxy hemoglobin.</PubMed_Title>
      <Author>Safo MK, et al.</Author>
      <Journal>Biochemistry.2005 Jun 14;44(23):8347-59.</Journal>
      <PubMed_ID>15938624</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-to-T(High) Quaternary Transitions in Human Hemoglobin: betaV1M deoxy low-salt (1 test set)</PDB_Title>
      <PDB_ID>1Y0T</PDB_ID>
      <Resolution>2.14</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y0T</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of Human hemoglobin E at 1.73 A resolution</PDB_Title>
      <PDB_ID>1NQP</PDB_ID>
      <Resolution>1.73</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NQP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CYANIDE ION$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallization and preliminary X-ray structural Studies of Hemoglobin A2 and Hemoglobin E, isolated from the blood samples of Beta-thalassemic patients</PubMed_Title>
      <Author>Dasgupta J, et al.</Author>
      <Journal>Biochem Biophys Res Commun.2003 Apr 4;303(2):619-23.</Journal>
      <PubMed_ID>12659864</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaY35F oxy (2MM IHP, 20% PEG) (1 test set)</PDB_Title>
      <PDB_ID>1YE2</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YE2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF HUMAN DEOXY HEMOGLOBIN A IN COMPLEX WITH XENON</PDB_Title>
      <PDB_ID>2W6V</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2W6V</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>GLYCEROL$PROTOPORPHYRIN IX CONTAINING FE$PHOSPHATE ION$SULFATE ION$XENON</Ligand_Name>
      <PubMed_Title>Pattern of Cavities in Globins: The Case of Human Hemoglobin.</PubMed_Title>
      <Author>Savino C, et al.</Author>
      <Journal>Biopolymers.2009 Dec;91(12):1097-107.</Journal>
      <PubMed_ID>19365817</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of partially ligated mutant of HbA</PDB_Title>
      <PDB_ID>1J7Y</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J7Y</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>Control of heme reactivity by diffusion: structural basis and functional characterization in hemoglobin mutants.</PubMed_Title>
      <Author>Miele AE, et al.</Author>
      <Journal>Biochemistry.2001 Dec 4;40(48):14449-58.</Journal>
      <PubMed_ID>11724557</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The T-to-T High Transitions in Human Hemoglobin: wild-type deoxy Hb A (low salt, one test set)</PDB_Title>
      <PDB_ID>1XXT</PDB_ID>
      <Resolution>1.91</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XXT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Carbonmonoxy Hemoglobin at 2.16 A: A Snapshot of the Allosteric Transition</PDB_Title>
      <PDB_ID>1LJW</PDB_ID>
      <Resolution>2.16</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LJW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>Structure of human carbonmonoxyhemoglobin at 2.16 A: a snapshot of the allosteric transition.</PubMed_Title>
      <Author>Safo MK, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2002 Dec;58(Pt 12):2031-7. Epub  2002 Nov 23.</Journal>
      <PubMed_ID>12454461</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: alphaY140F oxy (2MM IHP, 20% PEG) (1 test set)</PDB_Title>
      <PDB_ID>1YDZ</PDB_ID>
      <Resolution>3.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YDZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>1.25A resolution crystal structure of human hemoglobin in the oxy form</PDB_Title>
      <PDB_ID>2DN1</PDB_ID>
      <Resolution>1.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2DN1</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$TOLUENE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>1.25 a resolution crystal structures of human haemoglobin in the oxy, deoxy and carbonmonoxy forms.</PubMed_Title>
      <Author>Park SY, et al.</Author>
      <Journal>J Mol Biol.2006 Jul 14;360(3):690-701. Epub  2006 May 30.</Journal>
      <PubMed_ID>16765986</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaW37H OXY (2MM IHP, 20% PEG) (10 test sets)</PDB_Title>
      <PDB_ID>1YG5</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YG5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CROSSLINKED, DEOXY HUMAN HEMOGLOBIN A</PDB_Title>
      <PDB_ID>1BIJ</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BIJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>BUT-2-ENEDIAL$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystal structure of Lysbeta(1)82-Lysbeta(2)82 crosslinked hemoglobin: a possible allosteric intermediate</PubMed_Title>
      <Author>Fernandez EJ, et al.</Author>
      <Journal>J Mol Biol.2000 Mar 10;296(5):1245-56.</Journal>
      <PubMed_ID>10698631</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DEOXY RHB1.2 (RECOMBINANT HEMOGLOBIN)</PDB_Title>
      <PDB_ID>1C7D</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1C7D</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Genetically crosslinked hemoglobin: a structural study.</PubMed_Title>
      <Author>Brucker EA, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2000 Jul;56(Pt 7):812-6.</Journal>
      <PubMed_ID>10930828</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HEMOGLOBIN (VAL BETA1 MET, TRP BETA37 TYR) MUTANT</PDB_Title>
      <PDB_ID>1A00</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1A00</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>High-resolution crystal structures of human hemoglobin with mutations at tryptophan 37beta: structural basis for a high-affinity T-state,.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.1998 Mar 31;37(13):4358-73.</Journal>
      <PubMed_ID>9521756</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T STATE HUMAN HEMOGLOBIN [ALPHA V96W], ALPHA AQUOMET, BETA DEOXY</PDB_Title>
      <PDB_ID>1VWT</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1VWT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>Novel water-mediated hydrogen bonds as the structural basis for the low oxygen affinity of the blood substitute candidate rHb(alpha 96Val--&gt;Trp).</PubMed_Title>
      <Author>Puius YA, et al.</Author>
      <Journal>Biochemistry.1998 Jun 30;37(26):9258-65.</Journal>
      <PubMed_ID>9649306</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>OXY HEMOGLOBIN (88% RELATIVE HUMIDITY)</PDB_Title>
      <PDB_ID>1LFV</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LFV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Structures of human oxy- and deoxyhaemoglobin at different levels of humidity: variability in the T state.</PubMed_Title>
      <Author>Biswal BK, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2002 Jul;58(Pt 7):1155-61. Epub  2002 Jun 20.</Journal>
      <PubMed_ID>12077435</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Direct observation of photolysis-induced tertiary structural changes in human haemoglobin; Crystal structure of alpha(Ni)-beta(Fe) hemoglobin (laser photolysed)</PDB_Title>
      <PDB_ID>1J41</PDB_ID>
      <Resolution>1.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J41</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>BUT-2-ENEDIAL$CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$PROTOPORPHYRIN IX CONTAINING NI(II)</Ligand_Name>
      <PubMed_Title>Direct observation of photolysis-induced tertiary structural changes in hemoglobin</PubMed_Title>
      <Author>Adachi S, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A.2003 Jun 10;100(12):7039-44. Epub  2003 May 28.</Journal>
      <PubMed_ID>12773618</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaW37A OXY (10 test sets)</PDB_Title>
      <PDB_ID>1YEO</PDB_ID>
      <Resolution>2.22</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YEO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH-RESOLUTION X-RAY STUDY OF DEOXY RECOMBINANT HUMAN HEMOGLOBINS SYNTHESIZED FROM BETA-GLOBINS HAVING MUTATED AMINO TERMINI</PDB_Title>
      <PDB_ID>1DXT</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DXT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>High-resolution X-ray study of deoxy recombinant human hemoglobins synthesized from beta-globins having mutated amino termini.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.1992 Sep 15;31(36):8640-7.</Journal>
      <PubMed_ID>1390648</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>OXY HEMOGLOBIN (93% RELATIVE HUMIDITY)</PDB_Title>
      <PDB_ID>1LFQ</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LFQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Structures of human oxy- and deoxyhaemoglobin at different levels of humidity: variability in the T state.</PubMed_Title>
      <Author>Biswal BK, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2002 Jul;58(Pt 7):1155-61. Epub  2002 Jun 20.</Journal>
      <PubMed_ID>12077435</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>MAGNESIUM(II)-AND ZINC(II)-PROTOPORPHYRIN IX'S STABILIZE THE LOWEST OXYGEN AFFINITY STATE OF HUMAN HEMOGLOBIN EVEN MORE STRONGLY THAN DEOXYHEME</PDB_Title>
      <PDB_ID>1QSH</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QSH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING MG$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Magnesium(II) and zinc(II)-protoporphyrin IX's stabilize the lowest oxygen affinity state of human hemoglobin even more strongly than deoxyheme.</PubMed_Title>
      <PubMed_ID>10512707</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: alphaR92A oxy (2mM IHP, 20% PEG) (10 test sets)</PDB_Title>
      <PDB_ID>1Y8W</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y8W</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaY145G deoxy low-salt (1 test set)</PDB_Title>
      <PDB_ID>1Y83</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y83</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaD99A deoxy low-salt (10 test sets)</PDB_Title>
      <PDB_ID>1Y5K</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y5K</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Deoxyhemoglobin in Absence of Any Anions</PDB_Title>
      <PDB_ID>1KD2</PDB_ID>
      <Resolution>1.87</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1KD2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>The X-Ray Structure of Iso-Ionic Deoxy-Hb Crystal: The High Affinity T-state of Human Hb and the Mechanism of Chloride Regulation of Hb Cooperative Oxygen Binding.</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>T-to-T(high) quaternary transitions in human hemoglobin: betaH97A oxy (2MM IHP, 20% PEG) (1 test set)</PDB_Title>
      <PDB_ID>1YGF</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YGF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystalline Human Carbonmonoxy Hemoglobin C Exhibits The R2 Quaternary State at Neutral pH In The Presence of Polyethylene Glycol: The 2.1 Angstrom Resolution Crystal Structure</PDB_Title>
      <PDB_ID>1M9P</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1M9P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>COHbC and COHbS crystallize in the R2 quaternary state at neutral pH in the presence of PEG 4000.</PubMed_Title>
      <Author>Patskovska LN, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2005 May;61(Pt 5):566-73. Epub  2005 Apr 20.</Journal>
      <PubMed_ID>15858266</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>R STATE HUMAN HEMOGLOBIN [ALPHA V96W], CARBONMONOXY</PDB_Title>
      <PDB_ID>1RVW</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1RVW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>Novel water-mediated hydrogen bonds as the structural basis for the low oxygen affinity of the blood substitute candidate rHb(alpha 96Val--&gt;Trp).</PubMed_Title>
      <Author>Puius YA, et al.</Author>
      <Journal>Biochemistry.1998 Jun 30;37(26):9258-65.</Journal>
      <PubMed_ID>9649306</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The high salt (phosphate) crystal structure of deoxy hemoglobin E (GLU26LYS) at physiological pH (pH 7.35)</PDB_Title>
      <PDB_ID>3DUT</PDB_ID>
      <Resolution>1.55</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DUT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>The high salt (phosphate) crystal structure of  deoxy              hemoglobin E (GLU26LYS) at physiological pH (pH 7.35)</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of deoxy human hemoglobin complexed with two L35 molecules</PDB_Title>
      <PDB_ID>2D60</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2D60</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03910091</ASD_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]- 2
-METHYLPROPANOIC ACID</Ligand_Name>
      <PubMed_Title>R-state haemoglobin with low oxygen affinity: crystal structures of deoxy human and carbonmonoxy horse haemoglobin bound to the effector molecule L35</PubMed_Title>
      <Author>Yokoyama T, et al.</Author>
      <Journal>J Mol Biol.2006 Feb 24;356(3):790-801. Epub  2005 Dec 21.</Journal>
      <PubMed_ID>16403522</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH-RESOLUTION X-RAY STUDY OF DEOXY RECOMBINANT HUMAN HEMOGLOBINS SYNTHESIZED FROM BETA-GLOBINS HAVING MUTATED AMINO TERMINI</PDB_Title>
      <PDB_ID>1DXV</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DXV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>High-resolution X-ray study of deoxy recombinant human hemoglobins synthesized from beta-globins having mutated amino termini.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.1992 Sep 15;31(36):8640-7.</Journal>
      <PubMed_ID>1390648</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION CRYSTAL STRUCTURE OF DEOXY HEMOGLOBIN COMPLEXED WITH A POTENT ALLOSTERIC EFFECTOR</PDB_Title>
      <PDB_ID>1G9V</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1G9V</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03910095</ASD_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]- PHENOXY}-2-METHYLPROPIONIC ACID$SULFATE ION</Ligand_Name>
      <PubMed_Title>High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector.</PubMed_Title>
      <Author>Safo MK, et al.</Author>
      <Journal>Protein Sci.2001 May;10(5):951-7.</Journal>
      <PubMed_ID>11316875</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Deoxy hemoglobin (A-GLY-C:V1M,L29W,H58Q; B,D:V1M)</PDB_Title>
      <PDB_ID>1O1L</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1O1L</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
    </PDB>
    <PDB>
      <PDB_Title>HEMOGLOBIN A (HUMAN, DEOXY, HIGH SALT)</PDB_Title>
      <PDB_ID>1BZ0</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BZ0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Accommodation of insertions in helices: the mutation in hemoglobin Catonsville (Pro 37 alpha-Glu-Thr 38 alpha) generates a 3(10)--&gt;alpha bulge.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.1993 Mar 16;32(10):2509-13.</Journal>
      <PubMed_ID>8448109</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE STRUCTURE OF HUMAN CARBONMONOXY HAEMOGLOBIN AT 2.7 ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>2HCO</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HCO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>The structure of human carbonmonoxy haemoglobin at 2.7 A resolution.</PubMed_Title>
      <Author>Baldwin JM, et al.</Author>
      <Journal>J Mol Biol.1980 Jan 15;136(2):103-28.</Journal>
      <PubMed_ID>7373648</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>wild-type hemoglobin deoxy no-salt</PDB_Title>
      <PDB_ID>1XZ2</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XZ2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Intersubunit interactions associated with tyr42alpha stabilize the quaternary-T tetramer but are not major quaternary constraints in deoxyhemoglobin</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Mar 15;44(10):3806-20.</Journal>
      <PubMed_ID>15751957</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-to-THigh Quaternary Transitions in Human Hemoglobin: alphaP95A deoxy low-salt</PDB_Title>
      <PDB_ID>1XZV</PDB_ID>
      <Resolution>2.11</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XZV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DEOXY RHB1.0 (RECOMBINANT HEMOGLOBIN)</PDB_Title>
      <PDB_ID>1C7B</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1C7B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Genetically crosslinked hemoglobin: a structural study.</PubMed_Title>
      <Author>Brucker EA, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2000 Jul;56(Pt 7):812-6.</Journal>
      <PubMed_ID>10930828</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaY35A deoxy low-salt (1 test set)</PDB_Title>
      <PDB_ID>1Y31</PDB_ID>
      <Resolution>2.13</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y31</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The low salt (PEG) crystal structure of CO Hemoglobin E (betaE26K) approaching physiological pH (pH 7.5)</PDB_Title>
      <PDB_ID>1YVQ</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YVQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystal structures of CO Hemoglobin E (betaE26K) approaching physiological pH (pH 7.5)</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF HUMAN OXYHAEMOGLOBIN AT 2.1 ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>1HHO</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HHO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE$PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>Structure of human oxyhaemoglobin at 2.1 A resolution.</PubMed_Title>
      <Author>Shaanan B, et al.</Author>
      <Journal>J Mol Biol.1983 Nov 25;171(1):31-59.</Journal>
      <PubMed_ID>6644819</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural Basis for the Potent Antisickling Effect of a Novel Class of 5-Membered Heterocyclic Aldehydic Compounds</PDB_Title>
      <PDB_ID>1QXE</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QXE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>5-HYDROXYMETHYL-FURFURAL$PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE$SULFATE ION</Ligand_Name>
      <PubMed_Title>Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds</PubMed_Title>
      <Author>Safo MK, et al.</Author>
      <Journal>J Med Chem.2004 Sep 9;47(19):4665-76.</Journal>
      <PubMed_ID>15341482</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-to-THigh Quaternary Transitions in Human Hemoglobin: alphaD94G deoxy low-salt</PDB_Title>
      <PDB_ID>1XZU</PDB_ID>
      <Resolution>2.16</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XZU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaW37H deoxy low-salt (10 test sets)</PDB_Title>
      <PDB_ID>1Y4B</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y4B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystalline Human Carbonmonoxy Hemoglobin S (Liganded Sickle Cell Hemoglobin) Exhibits The R2 Quaternary State At Neutral pH In The Presence Of Polyethylene Glycol: The 2.1 Angstrom Resolution Crystal Structure</PDB_Title>
      <PDB_ID>1NEJ</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NEJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>COHbC and COHbS crystallize in the R2 quaternary state at neutral pH in the presence of PEG 4000.</PubMed_Title>
      <Author>Patskovska LN, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2005 May;61(Pt 5):566-73. Epub  2005 Apr 20.</Journal>
      <PubMed_ID>15858266</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaW37Y deoxy low-salt (10 test sets)</PDB_Title>
      <PDB_ID>1Y46</PDB_ID>
      <Resolution>2.22</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y46</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaY35F deoxy low-salt (1 test set)</PDB_Title>
      <PDB_ID>1Y35</PDB_ID>
      <Resolution>2.12</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y35</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural Basis for the Potent Antisickling Effect of a Novel Class of 5-Membered Heterocyclic Aldehydic Compounds</PDB_Title>
      <PDB_ID>1QXD</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QXD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>FURFURAL$PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds</PubMed_Title>
      <Author>Safo MK, et al.</Author>
      <Journal>J Med Chem.2004 Sep 9;47(19):4665-76.</Journal>
      <PubMed_ID>15341482</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>MAGNESIUM(II)-AND ZINC(II)-PROTOPORPHYRIN IX'S STABILIZE THE LOWEST OXYGEN AFFINITY STATE OF HUMAN HEMOGLOBIN EVEN MORE STRONGLY THAN DEOXYHEME</PDB_Title>
      <PDB_ID>1QSI</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QSI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING MG$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Magnesium(II) and zinc(II)-protoporphyrin IX's stabilize the lowest oxygen affinity state of human hemoglobin even more strongly than deoxyheme.</PubMed_Title>
      <Author>Miyazaki G, et al.</Author>
      <Journal>J Mol Biol.1999 Oct 8;292(5):1121-36.</Journal>
      <PubMed_ID>10512707</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>OXY HEMOGLOBIN (90% RELATIVE HUMIDITY)</PDB_Title>
      <PDB_ID>1LFT</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LFT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Structures of human oxy- and deoxyhaemoglobin at different levels of humidity: variability in the T state.</PubMed_Title>
      <Author>Biswal BK, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2002 Jul;58(Pt 7):1155-61. Epub  2002 Jun 20.</Journal>
      <PubMed_ID>12077435</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystallographic Analysis of the Interaction of Nitric Oxide with Quaternary-T Human Hemoglobin, HEMOGLOBIN EXPOSED TO NO UNDER AEROBIC CONDITIONS</PDB_Title>
      <PDB_ID>1RQ4</PDB_ID>
      <Resolution>2.11</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1RQ4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$NITRIC OXIDE</Ligand_Name>
      <PubMed_Title>Crystallographic analysis of the interaction of nitric oxide with quaternary-T human hemoglobin.</PubMed_Title>
      <Author>Chan NL, et al.</Author>
      <Journal>Biochemistry.2004 Jan 13;43(1):118-32.</Journal>
      <PubMed_ID>14705937</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>1.25A resolution crystal structure of human hemoglobin in the deoxy form</PDB_Title>
      <PDB_ID>2DN2</PDB_ID>
      <Resolution>1.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2DN2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>1.25 a resolution crystal structures of human haemoglobin in the oxy, deoxy and carbonmonoxy forms.</PubMed_Title>
      <Author>Park SY, et al.</Author>
      <Journal>J Mol Biol.2006 Jul 14;360(3):690-701. Epub  2006 May 30.</Journal>
      <PubMed_ID>16765986</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>OXYGEN AFFINITY MODULATION BY THE N-TERMINI OF THE BETA CHAINS IN HUMAN AND BOVINE HEMOGLOBIN</PDB_Title>
      <PDB_ID>2HHE</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HHE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Chloride ion independence of the Bohr effect in a mutant human hemoglobin beta (V1M+H2deleted).</PubMed_Title>
      <Author>Pechik I, et al.</Author>
      <Journal>Biochemistry.1996 Feb 13;35(6):1935-45.</Journal>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of oxy-human hemoglobin Bassett at 2.15 angstrom</PDB_Title>
      <PDB_ID>1R1X</PDB_ID>
      <Resolution>2.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1R1X</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$TOLUENE</Ligand_Name>
      <PubMed_Title>Characterization of hemoglobin bassett (alpha94Asp--&gt;Ala), a variant with very low oxygen affinity</PubMed_Title>
      <Author>Abdulmalik O, et al.</Author>
      <Journal>Am J Hematol.2004 Nov;77(3):268-76.</Journal>
      <PubMed_ID>15495251</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Deoxy hemoglobin (A-GLYGLYGLY-C:V1M,L29W; B,D:V1M)</PDB_Title>
      <PDB_ID>1O1N</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1O1N</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
    </PDB>
    <PDB>
      <PDB_Title>DEOXY (BETA-(C93A,C112G)) HUMAN HEMOGLOBIN</PDB_Title>
      <PDB_ID>1GBU</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1GBU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>Cysteines beta93 and beta112 as probes of conformational and functional events at the human hemoglobin subunit interfaces.</PubMed_Title>
      <Author>Vasquez G.B, et al.</Author>
      <Journal>Biophys J. 1999 Jan;76(1 Pt 1):88-97.</Journal>
      <PubMed_ID>9876125</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE CRYSTAL STRUCTURE OF HUMAN DEOXYHAEMOGLOBIN AT 1.74 ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>2HHB</PDB_ID>
      <Resolution>1.74</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HHB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>The crystal structure of human deoxyhaemoglobin at 1.74 A resolution</PubMed_Title>
      <Author>Fermi G, et al.</Author>
      <Journal>J Mol Biol.1984 May 15;175(2):159-74.</Journal>
      <PubMed_ID>6726807</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Direct observation of photolysis-induced tertiary structural changes in human hemoglobin; Crystal structure of alpha(Fe)-beta(Ni) hemoglobin (laser photolysed)</PDB_Title>
      <PDB_ID>1J3Y</PDB_ID>
      <Resolution>1.55</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J3Y</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>BUT-2-ENEDIAL$CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$PROTOPORPHYRIN IX CONTAINING NI(II)</Ligand_Name>
      <PubMed_Title>Direct observation of photolysis-induced tertiary structural changes in hemoglobin</PubMed_Title>
      <Author>Adachi S, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A.2003 Jun 10;100(12):7039-44. Epub  2003 May 28.</Journal>
      <PubMed_ID>12773618</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaW37G OXY (10 test sets)</PDB_Title>
      <PDB_ID>1YEU</PDB_ID>
      <Resolution>2.12</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YEU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Deoxy hemoglobin (A,C:V1M; B,D:V1M,V67W)</PDB_Title>
      <PDB_ID>1O1K</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1O1K</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
    </PDB>
    <PDB>
      <PDB_Title>T-to-THigh Quaternary Transitions in Human Hemoglobin: alphaY140A deoxy low-salt</PDB_Title>
      <PDB_ID>1Y0A</PDB_ID>
      <Resolution>2.22</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y0A</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-to-THigh Quaternary Transitions in Human Hemoglobin: alphaR92A deoxy low-salt</PDB_Title>
      <PDB_ID>1XZ7</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XZ7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A triply ligated crystal structure of relaxed state human hemoglobin</PDB_Title>
      <PDB_ID>3D17</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3D17</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$TOLUENE$PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>A triply ligated crystal structure of relaxed state human hemoglobin</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Carbonmonoxy-Haemoglobin at 1.25 A Resolution</PDB_Title>
      <PDB_ID>1IRD</PDB_ID>
      <Resolution>1.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1IRD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Carbonmonoxy-Haemoglobin at 1.25 A Resolution</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Deoxy hemoglobin (A,C:V1M,V62L; B,D:V1M,V67L)</PDB_Title>
      <PDB_ID>1O1O</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1O1O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaP100G deoxy low-salt (1 test set)</PDB_Title>
      <PDB_ID>1Y7D</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y7D</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION CRYSTAL STRUCTURES AND COMPARISONS OF T STATE DEOXYHAEMOGLOBIN AND TWO LIGANDED T-STATE HAEMOGLOBINS: T(ALPHA-OXY)HAEMOGLOBIN AND T(MET)HAEMOGLOBIN</PDB_Title>
      <PDB_ID>1HGC</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HGC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>High resolution crystal structures and comparisons of T-state deoxyhaemoglobin and two liganded T-state haemoglobins: T(alpha-oxy)haemoglobin and T(met)haemoglobin.</PubMed_Title>
      <Author>Liddington R, et al.</Author>
      <Journal>J Mol Biol.1992 Nov 20;228(2):551-79.</Journal>
      <PubMed_ID>1453464</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CROSS-LINKED, CARBONMONOXY HEMOGLOBIN A</PDB_Title>
      <PDB_ID>1SDL</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1SDL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$1,3,5-BENZENETRICARBOXYLIC ACID</Ligand_Name>
      <PubMed_Title>Allosteric transition intermediates modelled by crosslinked haemoglobins.</PubMed_Title>
      <Author>Schumacher MA, et al.</Author>
      <Journal>Nature.1995 May 4;375(6526):84-7.</Journal>
      <PubMed_ID>7723849</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HEMOGLOBIN (ALPHA V1M) MUTANT</PDB_Title>
      <PDB_ID>1BZZ</PDB_ID>
      <Resolution>1.59</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BZZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Structural and functional properties of human hemoglobins reassembled after synthesis in Escherichia coli.</PubMed_Title>
      <Author>Hui HL, et al.</Author>
      <Journal>Biochemistry.1999 Jan 19;38(3):1040-9.</Journal>
      <PubMed_ID>9894000</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE 1.9 ANGSTROM STRUCTURE OF DEOXY-BETA4 HEMOGLOBIN: ANALYSIS OF THE PARTITIONING OF QUATERNARY-ASSOCIATED AND LIGAND-INDUCED CHANGES IN TERTIARY STRUCTURE</PDB_Title>
      <PDB_ID>1CBL</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CBL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>The 1.9 A structure of deoxy beta 4 hemoglobin. Analysis of the partitioning of quaternary-associated and ligand-induced changes in tertiary structure.</PubMed_Title>
      <Author>Borgstahl GE, et al.</Author>
      <Journal>J Mol Biol.1994 Feb 25;236(3):831-43.</Journal>
      <PubMed_ID>8114097</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaW37A deoxy low-salt (10 test sets)</PDB_Title>
      <PDB_ID>1Y4F</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y4F</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>1.25A resolution crystal structure of human hemoglobin in the carbonmonoxy form</PDB_Title>
      <PDB_ID>2DN3</PDB_ID>
      <Resolution>1.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2DN3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>1.25 a resolution crystal structures of human haemoglobin in the oxy, deoxy and carbonmonoxy forms.</PubMed_Title>
      <Author>Park SY, et al.</Author>
      <Journal>J Mol Biol.2006 Jul 14;360(3):690-701. Epub  2006 May 30.</Journal>
      <PubMed_ID>16765986</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of deoxy-human hemoglobin Bassett at 1.8 angstrom</PDB_Title>
      <PDB_ID>1R1Y</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1R1Y</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>Characterization of hemoglobin bassett (alpha94Asp--&gt;Ala), a variant with very low oxygen affinity</PubMed_Title>
      <Author>Abdulmalik O, et al.</Author>
      <Journal>Am J Hematol.2004 Nov;77(3):268-76.</Journal>
      <PubMed_ID>15495251</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CROSS-LINKED HUMAN HEMOGLOBIN DEOXY</PDB_Title>
      <PDB_ID>1CLS</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CLS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>SEBACIC ACID$PROTOPORPHYRIN IX CONTAINING FE$OXYGEN ATOM$SULFATE ION</Ligand_Name>
      <PubMed_Title>Positive and negative cooperativities at subsequent steps of oxygenation regulate the allosteric behavior of multistate sebacylhemoglobin.</PubMed_Title>
      <Author>Bucci E, et al.</Author>
      <Journal>Biochemistry.1996 Mar 19;35(11):3418-25.</Journal>
      <PubMed_ID>8639491</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>REFINED CRYSTAL STRUCTURE OF DEOXYHEMOGLOBIN S. I. RESTRAINED LEAST-SQUARES REFINEMENT AT 3.0-ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>1HBS</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HBS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Refined crystal structure of deoxyhemoglobin S. I. Restrained least-squares refinement at 3.0-A resolution.</PubMed_Title>
      <Author>Padlan EA, et al.</Author>
      <Journal>J Biol Chem.1985 Jul 15;260(14):8272-9.</Journal>
      <PubMed_ID>4008491</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF HUMAN FOETAL DEOXYHAEMOGLOBIN</PDB_Title>
      <PDB_ID>1FDH</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FDH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Structure of human foetal deoxyhaemoglobin.</PubMed_Title>
      <Author>Frier JA, et al.</Author>
      <Journal>J Mol Biol.1977 May 5;112(1):97-112.</Journal>
      <PubMed_ID>881729</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(high) quaternary transitions in human hemoglobin: betaP36A deoxy low-salt (10 test sets)</PDB_Title>
      <PDB_ID>1Y45</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y45</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE CRYSTAL STRUCTURE OF HUMAN DEOXYHAEMOGLOBIN AT 1.74 ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>4HHB</PDB_ID>
      <Resolution>1.74</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4HHB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>The crystal structure of human deoxyhaemoglobin at 1.74 A resolution</PubMed_Title>
      <Author>Fermi G, et al.</Author>
      <Journal>J Mol Biol.1984 May 15;175(2):159-74.</Journal>
      <PubMed_ID>6726807</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Glycated Human Haemoglobin</PDB_Title>
      <PDB_ID>3B75</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3B75</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>FRUCTOSE$ALPHA-D-GLUCOSE$PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE$PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>The effect of hemoglobin glycosylation on diabete linked oxidative stress</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>HIGH-RESOLUTION X-RAY STUDY OF DEOXYHEMOGLOBIN ROTHSCHILD 37BETA TRP-&gt; ARG: A MUTATION THAT CREATES AN INTERSUBUNIT CHLORIDE-BINDING SITE</PDB_Title>
      <PDB_ID>1HBA</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HBA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CHLORIDE ION$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>High-resolution X-ray study of deoxyhemoglobin Rothschild 37 beta Trp----Arg: a mutation that creates an intersubunit chloride-binding site.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.1992 Apr 28;31(16):4111-21.</Journal>
      <PubMed_ID>1567857</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structures of Unliganded and Half-Liganded Human Hemoglobin Derivatives Cross-Linked between Lys 82beta1 and Lys 82beta2</PDB_Title>
      <PDB_ID>1UIW</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1UIW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>BUT-2-ENEDIAL$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystal structures of unliganded and half-liganded human hemoglobin derivatives cross-linked between Lys 82beta1 and Lys 82beta2</PubMed_Title>
      <Author>Park SY, et al.</Author>
      <Journal>Biochemistry.2004 Jul 13;43(27):8711-7.</Journal>
      <PubMed_ID>15236579</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaH97A deoxy low-salt (1 test set)</PDB_Title>
      <PDB_ID>1Y5J</PDB_ID>
      <Resolution>2.03</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y5J</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-to-THigh Transitions in Human Hemoglobin: alpha Y42A deoxy low salt</PDB_Title>
      <PDB_ID>1XYE</PDB_ID>
      <Resolution>2.13</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XYE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Intersubunit interactions associated with tyr42alpha stabilize the quaternary-T tetramer but are not major quaternary constraints in deoxyhemoglobin</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Mar 15;44(10):3806-20.</Journal>
      <PubMed_ID>15751957</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaP36A oxy (2MM IHP, 20% PEG) (10 test sets)</PDB_Title>
      <PDB_ID>1YEN</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YEN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaW37E alpha zinc beta oxy (10 TEST SETS)</PDB_Title>
      <PDB_ID>1YGD</PDB_ID>
      <Resolution>2.73</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YGD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE$PROTOPORPHYRIN IX CONTAINING ZN</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>OXYGEN AFFINITY MODULATION BY THE N-TERMINI OF THE BETA-CHAINS IN HUMAN AND BOVINE HEMOGLOBIN</PDB_Title>
      <PDB_ID>2HHD</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HHD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>Crystallographic, molecular modeling, and biophysical characterization of the valine beta 67 (E11)--&gt;threonine variant of hemoglobin.</PubMed_Title>
      <Author>Pechik I, et al.</Author>
      <Journal>Biochemistry.1996 Feb 13;35(6):1935-45.</Journal>
      <PubMed_ID>8639677</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-to-thigh quaternary transitions in human hemoglobin: betaW37A oxy (2.2MM IHP, 13% PEG) (1 test set)</PDB_Title>
      <PDB_ID>1YIE</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YIE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human hemoglobin, nitrogen dioxide anion modified</PDB_Title>
      <PDB_ID>3D7O</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3D7O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$TOLUENE$NITRITE ION</Ligand_Name>
      <PubMed_Title>The nitrite anion binds to human hemoglobin via the uncommon O-nitrito mode.</PubMed_Title>
      <Author>Yi J, et al.</Author>
      <Journal>Biochemistry.2008 Aug 12;47(32):8247-9. Epub  2008 Jul 17.</Journal>
      <PubMed_ID>18630930</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DEOXY RHB1.1 (RECOMBINANT HEMOGLOBIN)</PDB_Title>
      <PDB_ID>1C7C</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1C7C</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Genetically crosslinked hemoglobin: a structural study.</PubMed_Title>
      <Author>Brucker EA, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2000 Jul;56(Pt 7):812-6.</Journal>
      <PubMed_ID>10930828</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>R-STATE HUMAN CARBONMONOXYHEMOGLOBIN ALPHA-A53S</PDB_Title>
      <PDB_ID>1AJ9</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1AJ9</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>Human carboxyhemoglobin at 2.2 A resolution: structure and solvent comparisons of R-state, R2-state and T-state hemoglobins.</PubMed_Title>
      <Author>Vasquez G.B, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr. 1998 May 1;54(Pt 3):355-66.</Journal>
      <PubMed_ID>9761903</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF S-NITROSO-NITROSYL HUMAN HEMOGLOBIN A</PDB_Title>
      <PDB_ID>1BUW</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BUW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$NITRIC OXIDE</Ligand_Name>
      <PubMed_Title>Crystal structure of the S-nitroso form of liganded human hemoglobin.</PubMed_Title>
      <Author>Chan NL, et al.</Author>
      <Journal>Biochemistry.1998 Nov 24;37(47):16459-64.</Journal>
      <PubMed_ID>9843411</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystallographic Analysis of the Interaction of Nitric Oxide with Quaternary-T Human Deoxyhemoglobin, Deoxyhemoglobin</PDB_Title>
      <PDB_ID>1RQ3</PDB_ID>
      <Resolution>1.91</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1RQ3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic analysis of the interaction of nitric oxide with quaternary-T human hemoglobin.</PubMed_Title>
      <Author>Chan NL, et al.</Author>
      <Journal>Biochemistry.2004 Jan 13;43(1):118-32.</Journal>
      <PubMed_ID>14705937</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HEMOGLOBIN THIONVILLE: AN ALPHA-CHAIN VARIANT WITH A SUBSTITUTION OF A GLUTAMATE FOR VALINE AT NA-1 AND HAVING AN ACETYLATED METHIONINE NH2 TERMINUS</PDB_Title>
      <PDB_ID>1BAB</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BAB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>Hemoglobin Thionville. An alpha-chain variant with a substitution of a glutamate for valine at NA-1 and having an acetylated methionine NH2 terminus.</PubMed_Title>
      <Author>Vasseur C, et al.</Author>
      <Journal>J Biol Chem.1992 Jun 25;267(18):12682-91.</Journal>
      <PubMed_ID>1618774</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>OXY HEMOGLOBIN (84% RELATIVE HUMIDITY)</PDB_Title>
      <PDB_ID>1LFY</PDB_ID>
      <Resolution>3.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LFY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Structures of human oxy- and deoxyhaemoglobin at different levels of humidity: variability in the T state.</PubMed_Title>
      <Author>Biswal BK, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2002 Jul;58(Pt 7):1155-61. Epub  2002 Jun 20.</Journal>
      <PubMed_ID>12077435</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of deoxy HbalphaYQ, a mutant of HbA</PDB_Title>
      <PDB_ID>1J7S</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J7S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Control of heme reactivity by diffusion: structural basis and functional characterization in hemoglobin mutants.</PubMed_Title>
      <Author>Miele AE, et al.</Author>
      <Journal>Biochemistry.2001 Dec 4;40(48):14449-58.</Journal>
      <PubMed_ID>11724557</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>OXY T STATE HAEMOGLOBIN: OXYGEN BOUND AT ALL FOUR HAEMS</PDB_Title>
      <PDB_ID>1GZX</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GZX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystal Structure of T State Haemoglobin with Oxygen Bound at All Four Haems.</PubMed_Title>
      <Author>Paoli M, et al.</Author>
      <Journal>J Mol Biol.1996 Mar 8;256(4):775-92.</Journal>
      <PubMed_ID>8642597</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaF42A deoxy low-salt (1 test set)</PDB_Title>
      <PDB_ID>1Y4Q</PDB_ID>
      <Resolution>2.11</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y4Q</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
    </PDB>
    <PDB>
      <PDB_Title>THE CRYSTAL STRUCTURE OF HUMAN DEOXYHAEMOGLOBIN AT 1.74 ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>3HHB</PDB_ID>
      <Resolution>1.74</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3HHB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>The crystal structure of human deoxyhaemoglobin at 1.74 A resolution</PubMed_Title>
      <Author>Fermi G, et al.</Author>
      <Journal>J Mol Biol.1984 May 15;175(2):159-74.</Journal>
      <PubMed_ID>6726807</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>X-ray Crystallographic Analyses of Symmetrical Allosteric Effectors of Hemoglobin. Compounds Designed to Link Primary and Secondary Binding Sites</PDB_Title>
      <PDB_ID>1K0Y</PDB_ID>
      <Resolution>1.87</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1K0Y</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>2-{4-[(3{2-[4-(1-CARBOXY-1-METHYL-ETHOXY)- PHENYL]-ACETYLAMINO}-PHENYLCARBAMOYL)
-METHYL]- PHENOXY}-2-METHYL-PROPIONIC ACID$PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>X-ray crystallographic analyses of symmetrical allosteric effectors of hemoglobin: compounds designed to link primary and secondary binding sites.</PubMed_Title>
      <Author>Safo MK, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2002 Apr;58(Pt 4):634-44. Epub  2002 Mar 22.</Journal>
      <PubMed_ID>11914488</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>REFINEMENT OF A PARTIALLY OXYGENATED T STATE HAEMOGLOBIN AT 1.5 ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>1THB</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1THB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$INOSITOL HEXAKISPHOSPHATE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Refinement of a partially oxygenated T state human haemoglobin at 1.5 A resolution.</PubMed_Title>
      <PubMed_ID>2383372</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>MODULE-SUBSTITUTED CHIMERA HEMOGLOBIN BETA-ALPHA (F133V)</PDB_Title>
      <PDB_ID>1CH4</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CH4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystal structure of a protein with an artificial exon-shuffling, module M4-substituted chimera hemoglobin beta alpha, at 2.5 A resolution.</PubMed_Title>
      <Author>Shirai T, et al.</Author>
      <Journal>J Mol Biol.1999 Mar 26;287(2):369-82.</Journal>
      <PubMed_ID>10080899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Deoxy hemoglobin (A-GLY-C:V1M; B,D:V1M,C93A,N108K)</PDB_Title>
      <PDB_ID>1O1P</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1O1P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
    </PDB>
    <PDB>
      <PDB_Title>T-to-T(High) quaternary transitions in human hemoglobin: betaP100A oxy (2.2MM IHP, 20% PEG) (1 test set)</PDB_Title>
      <PDB_ID>1YIH</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YIH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DEOXYGENATED STRUCTURE OF A DISTAL POCKET HEMOGLOBIN MUTANT</PDB_Title>
      <PDB_ID>1QI8</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1QI8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Modulation of ligand binding in engineered human hemoglobin distal pocket.</PubMed_Title>
      <Author>Miele AE, et al.</Author>
      <Journal>J Mol Biol.1999 Jul 9;290(2):515-24.</Journal>
      <PubMed_ID>10390349</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION X-RAY STRUCTURES OF MYOGLOBIN-AND HEMOGLOBIN-ALKYL ISOCYANIDE COMPLEXES</PDB_Title>
      <PDB_ID>2HBD</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HBD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$METHYL ISOCYANIDE</Ligand_Name>
      <PubMed_Title>High Resolution X-Ray Structures of Myoglobin-and Hemoglobin-Alkyl Isocyanide Complexes</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>CYANOMET RHB1.1 (RECOMBINANT HEMOGLOBIN)</PDB_Title>
      <PDB_ID>1ABY</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ABY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CYANIDE ION$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Structures of a hemoglobin-based blood substitute: insights into the function of allosteric proteins.</PubMed_Title>
      <Author>Kroeger KS, et al.</Author>
      <Journal>Structure.1997 Feb 15;5(2):227-37.</Journal>
      <PubMed_ID>9032082</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaW37Y OXY (10 test sets)</PDB_Title>
      <PDB_ID>1YEQ</PDB_ID>
      <Resolution>2.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YEQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
    </PDB>
    <PDB>
      <PDB_Title>Deoxy hemoglobin (A-GLY-C:V1M,L29F,H58Q; B,D:V1M,L106W)</PDB_Title>
      <PDB_ID>1O1J</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1O1J</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION X-RAY STRUCTURES OF MYOGLOBIN-AND HEMOGLOBIN-ALKYL ISOCYANIDE COMPLEXES</PDB_Title>
      <PDB_ID>2HBC</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HBC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ETHYL ISOCYANIDE$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>High Resolution X-Ray Structures of Myoglobin-and Hemoglobin-Alkyl Isocyanide Complexes</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Human hemoglobin D Los Angeles: crystal structure</PDB_Title>
      <PDB_ID>2YRS</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2YRS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Human Hemoglobin D Los Angeles: crystal structure</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaV33A oxy (2MM IHP, 20% PEG) (1 test set)</PDB_Title>
      <PDB_ID>1YE0</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YE0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF NICKEL RECONSTITUTED HEMOGLOBIN-A CASE FOR PERMANENT, T-STATE HEMOGLOBIN</PDB_Title>
      <PDB_ID>1FN3</PDB_ID>
      <Resolution>2.48</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FN3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING NI(II)</Ligand_Name>
      <PubMed_Title>Crystal Structure of Nickel Reconstituted Hemoglobin - A Case for Permanent, T-State Hemoglobin</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>HEMOGLOBIN (VAL BETA1 MET) MUTANT</PDB_Title>
      <PDB_ID>1A0Z</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1A0Z</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>High-resolution crystal structures of human hemoglobin with mutations at tryptophan 37beta: structural basis for a high-affinity T-state,.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.1998 Mar 31;37(13):4358-73.</Journal>
      <PubMed_ID>9521756</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Direct observation of photolysis-induced tertiary structural changes in human haemoglobin; Crystal structure of alpha(Ni)-beta(Fe-CO) hemoglobin (laser unphotolysed)</PDB_Title>
      <PDB_ID>1J40</PDB_ID>
      <Resolution>1.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J40</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>BUT-2-ENEDIAL$CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$PROTOPORPHYRIN IX CONTAINING NI(II)</Ligand_Name>
      <PubMed_Title>Direct observation of photolysis-induced tertiary structural changes in hemoglobin</PubMed_Title>
      <Author>Adachi S, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A.2003 Jun 10;100(12):7039-44. Epub  2003 May 28.</Journal>
      <PubMed_ID>12773618</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CROSS-LINKED, CARBONMONOXY HEMOGLOBIN A</PDB_Title>
      <PDB_ID>1SDK</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1SDK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$1,3,5-BENZENETRICARBOXYLIC ACID</Ligand_Name>
      <PubMed_Title>Allosteric transition intermediates modelled by crosslinked haemoglobins.</PubMed_Title>
      <Author>Schumacher MA, et al.</Author>
      <Journal>Nature.1995 May 4;375(6526):84-7.</Journal>
      <PubMed_ID>7723849</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystallographic Analysis of the Interaction of Nitric Oxide with Quaternary-T Human Hemoglobin. Beta W73E hemoglobin exposed to NO under anaerobic conditions</PDB_Title>
      <PDB_ID>1RQA</PDB_ID>
      <Resolution>2.11</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1RQA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$NITRIC OXIDE</Ligand_Name>
      <PubMed_Title>Crystallographic analysis of the interaction of nitric oxide with quaternary-T human hemoglobin.</PubMed_Title>
      <Author>Chan NL, et al.</Author>
      <Journal>Biochemistry.2004 Jan 13;43(1):118-32.</Journal>
      <PubMed_ID>14705937</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Deoxy hemoglobin (A-GLYGLYGLY-C:V1M,L29F,H58Q B,D:V1M,V67W)</PDB_Title>
      <PDB_ID>1O1M</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1O1M</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
    </PDB>
    <PDB>
      <PDB_Title>DEOXY RHB1.1 (RECOMBINANT HEMOGLOBIN)</PDB_Title>
      <PDB_ID>1ABW</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ABW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$LEUCINE$METHIONINE</Ligand_Name>
      <PubMed_Title>Structures of a hemoglobin-based blood substitute: insights into the function of allosteric proteins.</PubMed_Title>
      <Author>Kroeger KS, et al.</Author>
      <Journal>Structure.1997 Feb 15;5(2):227-37.</Journal>
      <PubMed_ID>9032082</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE STRUCTURE OF HUMAN METHEMOGLOBIN. THE VARIATION OF A THEME</PDB_Title>
      <PDB_ID>1JY7</PDB_ID>
      <Resolution>3.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1JY7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Structures of human oxy- and deoxyhaemoglobin at different levels of humidity: variability in the T state.</PubMed_Title>
      <Author>Biswal BK, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2002 Jul;58(Pt 7):1155-61. Epub  2002 Jun 20.</Journal>
      <PubMed_ID>12077435</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of T-state human hemoglobin complexed with three L35 molecules</PDB_Title>
      <PDB_ID>2D5Z</PDB_ID>
      <Resolution>1.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2D5Z</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03910091</ASD_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]- 2
-METHYLPROPANOIC ACID</Ligand_Name>
      <PubMed_Title>R-state haemoglobin with low oxygen affinity: crystal structures of deoxy human and carbonmonoxy horse haemoglobin bound to the effector molecule L35</PubMed_Title>
      <Author>Yokoyama T, et al.</Author>
      <Journal>J Mol Biol.2006 Feb 24;356(3):790-801. Epub  2005 Dec 21.</Journal>
      <PubMed_ID>16403522</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaY35A oxy (2MM IHP, 20% PEG) (1 test set)</PDB_Title>
      <PDB_ID>1YE1</PDB_ID>
      <Resolution>4.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YE1</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CROSSLINKED HAEMOGLOBIN</PDB_Title>
      <PDB_ID>1HAC</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HAC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$2,6-DICARBOXYNAPHTHALENE</Ligand_Name>
      <PubMed_Title>Allosteric intermediates indicate R2 is the liganded hemoglobin end state.</PubMed_Title>
      <Author>Schumacher MA, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A.1997 Jul 22;94(15):7841-4.</Journal>
      <PubMed_ID>9223274</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of deoxy HbbetaYQ, a site directed mutant of HbA</PDB_Title>
      <PDB_ID>1J7W</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J7W</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Control of heme reactivity by diffusion: structural basis and functional characterization in hemoglobin mutants.</PubMed_Title>
      <Author>Miele AE, et al.</Author>
      <Journal>Biochemistry.2001 Dec 4;40(48):14449-58.</Journal>
      <PubMed_ID>11724557</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of deoxy-quaternary haemoglobin with liganded beta subunits</PDB_Title>
      <PDB_ID>1NIH</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NIH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$PROTOPORPHYRIN IX CONTAINING NI(II)$INOSITOL HEXAKISPHOSPHATE</Ligand_Name>
      <PubMed_Title>Structure of deoxy-quaternary haemoglobin with liganded beta subunits.</PubMed_Title>
      <Author>Luisi B, et al.</Author>
      <Journal>J Mol Biol.1990 Jul 5;214(1):7-14.</Journal>
      <PubMed_ID>2370669</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH-RESOLUTION X-RAY STUDY OF DEOXYHEMOGLOBIN ROTHSCHILD 37BETA TRP-&gt; ARG: A MUTATION THAT CREATES AN INTERSUBUNIT CHLORIDE-BINDING SITE</PDB_Title>
      <PDB_ID>1HBB</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HBB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>High-resolution X-ray study of deoxyhemoglobin Rothschild 37 beta Trp----Arg: a mutation that creates an intersubunit chloride-binding site.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.1992 Apr 28;31(16):4111-21.</Journal>
      <PubMed_ID>1567857</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaV33A deoxy low-salt (1 test set)</PDB_Title>
      <PDB_ID>1Y22</PDB_ID>
      <Resolution>2.16</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y22</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>OXY HEMOGLOBIN (25% METHANOL)</PDB_Title>
      <PDB_ID>1LFZ</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LFZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Structures of human oxy- and deoxyhaemoglobin at different levels of humidity: variability in the T state.</PubMed_Title>
      <Author>Biswal BK, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2002 Jul;58(Pt 7):1155-61. Epub  2002 Jun 20.</Journal>
      <PubMed_ID>12077435</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>ARTIFICIAL MUTANT (ALPHA Y42H) OF DEOXY HEMOGLOBIN</PDB_Title>
      <PDB_ID>1A3O</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1A3O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>The structures of deoxy human haemoglobin and the mutant Hb Tyralpha42His at 120 K.</PubMed_Title>
      <Author>Tame JR, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2000 Jul;56(Pt 7):805-11.</Journal>
      <PubMed_ID>10930827</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The high salt (phosphate) crystal structure of CO Hemoglobin E (Glu26Lys) at physiological pH (pH 7.35)</PDB_Title>
      <PDB_ID>1YVT</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YVT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$GLYCEROL$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>The high salt (phosphate) crystal structure of CO Hemoglobin E (Glu26Lys) at physiological pH (pH 7.35)</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>HEMOGLOBIN (VAL BETA1 MET, TRP BETA37 ALA) MUTANT</PDB_Title>
      <PDB_ID>1A01</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1A01</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>High-resolution crystal structures of human hemoglobin with mutations at tryptophan 37beta: structural basis for a high-affinity T-state,.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.1998 Mar 31;37(13):4358-73.</Journal>
      <PubMed_ID>9521756</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION CRYSTAL STRUCTURES AND COMPARISONS OF T STATE DEOXYHAEMOGLOBIN AND TWO LIGANDED T-STATE HAEMOGLOBINS: T(ALPHA-OXY)HAEMOGLOBIN AND T(MET)HAEMOGLOBIN</PDB_Title>
      <PDB_ID>1HGA</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HGA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>High resolution crystal structures and comparisons of T-state deoxyhaemoglobin and two liganded T-state haemoglobins: T(alpha-oxy)haemoglobin and T(met)haemoglobin.</PubMed_Title>
      <Author>Liddington R, et al.</Author>
      <Journal>J Mol Biol.1992 Nov 20;228(2):551-79.</Journal>
      <PubMed_ID>1453464</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Intersubunit Interactions Associated with Tyr42alpha Stabilize the Quaternary-T Tetramer but are not Major Quaternary Constraints in Deoxyhemoglobin: alphaY42A deoxyhemoglobin no-salt</PDB_Title>
      <PDB_ID>1XZ4</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XZ4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Intersubunit interactions associated with tyr42alpha stabilize the quaternary-T tetramer but are not major quaternary constraints in deoxyhemoglobin</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Mar 15;44(10):3806-20.</Journal>
      <PubMed_ID>15751957</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION CRYSTAL STRUCTURES AND COMPARISONS OF T STATE DEOXYHAEMOGLOBIN AND TWO LIGANDED T-STATE HAEMOGLOBINS: T(ALPHA-OXY)HAEMOGLOBIN AND T(MET)HAEMOGLOBIN</PDB_Title>
      <PDB_ID>1HGB</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HGB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>High resolution crystal structures and comparisons of T-state deoxyhaemoglobin and two liganded T-state haemoglobins: T(alpha-oxy)haemoglobin and T(met)haemoglobin.</PubMed_Title>
      <Author>Liddington R, et al.</Author>
      <Journal>J Mol Biol.1992 Nov 20;228(2):551-79.</Journal>
      <PubMed_ID>1453464</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF HAEMOGLOBIN IN THE DEOXY QUATERNARY STATE WITH LIGAND BOUND AT THE ALPHA HAEMS</PDB_Title>
      <PDB_ID>1COH</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1COH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING CO$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Structure of haemoglobin in the deoxy quaternary state with ligand bound at the alpha haems.</PubMed_Title>
      <Author>Luisi B, et al.</Author>
      <Journal>J Mol Biol.1989 Apr 20;206(4):723-36.</Journal>
      <PubMed_ID>2738915</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaP100A deoxy low-salt (1 test set)</PDB_Title>
      <PDB_ID>1Y7C</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y7C</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaW37G deoxy low-salt (10 test sets)</PDB_Title>
      <PDB_ID>1Y4G</PDB_ID>
      <Resolution>1.91</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y4G</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of Mutant Human Carbonmonoxyhemoglobin C (beta E6K) at 2.0 Angstrom Resolution in Phosphate Buffer.</PDB_Title>
      <PDB_ID>1K1K</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1K1K</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Structure of mutant human carbonmonoxyhemoglobin C (betaE6K) at 2.0 A resolution.</PubMed_Title>
      <Author>Dewan JC, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2002 Dec;58(Pt 12):2038-42. Epub  2002 Nov 23.</Journal>
      <PubMed_ID>12454462</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DEOXY HUMAN HEMOGLOBIN</PDB_Title>
      <PDB_ID>1A3N</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1A3N</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>The structures of deoxy human haemoglobin and the mutant Hb Tyralpha42His at 120 K.</PubMed_Title>
      <Author>Tame JR, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.2000 Jul;56(Pt 7):805-11.</Journal>
      <PubMed_ID>10930827</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DEOXYHEMOGLOBIN T38W (ALPHA CHAINS), V1G (ALPHA AND BETA CHAINS)</PDB_Title>
      <PDB_ID>1GLI</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GLI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>Probing the alpha 1 beta 2 interface of human hemoglobin by mutagenesis. Role of the FG-C contact regions.</PubMed_Title>
      <Author>Vallone B, et al.</Author>
      <Journal>J Biol Chem.1996 May 24;271(21):12472-80.</Journal>
      <PubMed_ID>8647854</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of deoxy-human hemoglobin beta6 glu-&gt;trp</PDB_Title>
      <PDB_ID>6HBW</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=6HBW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystal structure of deoxy-human hemoglobin beta6 Glu --&gt; Trp. Implications for the structure and formation of the sickle cell fiber.</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>HEMOGLOBIN (VAL BETA1 MET) MUTANT</PDB_Title>
      <PDB_ID>1A0U</PDB_ID>
      <Resolution>2.14</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1A0U</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>High-resolution crystal structures of human hemoglobin with mutations at tryptophan 37beta: structural basis for a high-affinity T-state,.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.1998 Mar 31;37(13):4358-73.</Journal>
      <PubMed_ID>9521756</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HEMOGLOBIN (ALPHA + MET) VARIANT</PDB_Title>
      <PDB_ID>1BZ1</PDB_ID>
      <Resolution>1.59</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BZ1</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Structural and functional properties of human hemoglobins reassembled after synthesis in Escherichia coli.</PubMed_Title>
      <Author>Hui HL, et al.</Author>
      <Journal>Biochemistry.1999 Jan 19;38(3):1040-9.</Journal>
      <PubMed_ID>9894000</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaL96A deoxy low-salt (1 test set)</PDB_Title>
      <PDB_ID>1Y5F</PDB_ID>
      <Resolution>2.14</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y5F</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION X-RAY STRUCTURES OF MYOGLOBIN-AND HEMOGLOBIN-ALKYL ISOCYANIDE COMPLEXES</PDB_Title>
      <PDB_ID>2HBF</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HBF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$N-PROPYL ISOCYANIDE</Ligand_Name>
      <PubMed_Title>High Resolution X-Ray Structures of Myoglobin-and Hemoglobin-Alkyl Isocyanide Complexes</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>HIGH-RESOLUTION X-RAY STUDY OF DEOXY RECOMBINANT HUMAN HEMOGLOBINS SYNTHESIZED FROM BETA-GLOBINS HAVING MUTATED AMINO TERMINI</PDB_Title>
      <PDB_ID>1DXU</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DXU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>High-resolution X-ray study of deoxy recombinant human hemoglobins synthesized from beta-globins having mutated amino termini.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.1992 Sep 15;31(36):8640-7.</Journal>
      <PubMed_ID>1390648</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-to-T(High) quaternary transitions in human hemoglobin: HbA OXY (2MM IHP, 20% PEG) (10 test sets)</PDB_Title>
      <PDB_ID>1YH9</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YH9</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(high) quaternary transitions in human hemoglobin: betaW37E deoxy low-salt (10 test sets)</PDB_Title>
      <PDB_ID>1Y4P</PDB_ID>
      <Resolution>1.98</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y4P</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: HbA OXY (5.0MM IHP, 20% PEG) (10 test sets)</PDB_Title>
      <PDB_ID>1YHE</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YHE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-to-THigh Quaternary Transitions in Human Hemoglobin: alphaY140F deoxy low-salt</PDB_Title>
      <PDB_ID>1Y0C</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y0C</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>(ALPHA-OXY, BETA-(C112G)DEOXY) T-STATE HUMAN HEMOGLOBIN</PDB_Title>
      <PDB_ID>1GBV</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1GBV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Cysteines beta93 and beta112 as probes of conformational and functional events at the human hemoglobin subunit interfaces.</PubMed_Title>
      <Author>Vasquez G.B, et al.</Author>
      <Journal>Biophys J. 1999 Jan;76(1 Pt 1):88-97.</Journal>
      <PubMed_ID>9876125</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF HUMAN CARBONMONOXYHEMOGLOBIN C (BETA E6K): TWO QUATERNARY STATES (R2 and R3) IN ONE CRYSTAL</PDB_Title>
      <PDB_ID>1YFF</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YFF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>Mechanism of Quaternary Transitions in Human Liganded Hemoglobin</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaC93A deoxy low-salt (1 test set)</PDB_Title>
      <PDB_ID>1Y4V</PDB_ID>
      <Resolution>1.84</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y4V</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of liganded hemoglobin in complex with a potent antisickling agent, INN-298</PDB_Title>
      <PDB_ID>3IC0</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3IC0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>2-[(2-methoxy-5-methylphenoxy)methyl]pyridine$PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE$SULFATE ION</Ligand_Name>
      <PubMed_Title>Structural and in Vitro Chracterization of Pridyl Derivatives of Benzaldehydes: Highly Potent Antisickling Agents</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION X-RAY STRUCTURES OF MYOGLOBIN-AND HEMOGLOBIN-ALKYL ISOCYANIDE COMPLEXES</PDB_Title>
      <PDB_ID>2HBE</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HBE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$N-BUTYL ISOCYANIDE</Ligand_Name>
      <PubMed_Title>High Resolution X-Ray Structures of Myoglobin-and Hemoglobin-Alkyl Isocyanide Complexes</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>T-to-T(High) Quaternary Transitions in Human Hemoglobin: alphaN97A deoxy low-salt</PDB_Title>
      <PDB_ID>1Y09</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y09</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A THIRD QUATERNARY STRUCTURE OF HUMAN HEMOGLOBIN A AT 1.7-ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>1BBB</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BBB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>A third quaternary structure of human hemoglobin A at 1.7-A resolution.</PubMed_Title>
      <Author>Silva MM, et al.</Author>
      <Journal>J Biol Chem.1992 Aug 25;267(24):17248-56.</Journal>
      <PubMed_ID>1512262</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CROSSLINKED HAEMOGLOBIN</PDB_Title>
      <PDB_ID>1HAB</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HAB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>4-CARBOXYCINNAMIC ACID$CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Allosteric intermediates indicate R2 is the liganded hemoglobin end state.</PubMed_Title>
      <Author>Schumacher MA, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A.1997 Jul 22;94(15):7841-4.</Journal>
      <PubMed_ID>9223274</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DEOXYGENATED STRUCTURE OF A DISTAL SITE HEMOGLOBIN MUTANT PLUS XE</PDB_Title>
      <PDB_ID>2W72</PDB_ID>
      <Resolution>1.07</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2W72</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$POTASSIUM ION$PHOSPHATE ION$SULFATE ION$XENON</Ligand_Name>
      <PubMed_Title>Pattern of Cavities in Globins: The Case of Human Hemoglobin.</PubMed_Title>
      <Author>Savino C, et al.</Author>
      <Journal>Biopolymers.2009 Dec;91(12):1097-107.</Journal>
      <PubMed_ID>19365817</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-to-THigh quaternary Transitions in Human Hemoglobin: betaV1M deoxy low-salt (10 test sets)</PDB_Title>
      <PDB_ID>1Y0W</PDB_ID>
      <Resolution>2.14</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y0W</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE STRUCTURE OF HUMAN CARBONMONOXY HAEMOGLOBIN AT 2.7 ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>1HCO</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HCO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>The structure of human carbonmonoxy haemoglobin at 2.7 A resolution.</PubMed_Title>
      <Author>Baldwin JM, et al.</Author>
      <Journal>J Mol Biol.1980 Jan 15;136(2):103-28.</Journal>
      <PubMed_ID>7373648</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE HIGH RESOLUTION CRYSTAL STRUCTURE OF DEOXYHEMOGLOBIN S</PDB_Title>
      <PDB_ID>2HBS</PDB_ID>
      <Resolution>2.05</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HBS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>The high resolution crystal structure of deoxyhemoglobin S.</PubMed_Title>
      <Author>Harrington DJ, et al.</Author>
      <Journal>J Mol Biol.1997 Sep 26;272(3):398-407.</Journal>
      <PubMed_ID>9325099</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE MUTATION BETA99 ASP-TYR STABILIZES Y-A NEW, COMPOSITE QUATERNARY STATE OF HUMAN HEMOGLOBIN</PDB_Title>
      <PDB_ID>1CMY</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CMY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>The mutation beta 99 Asp-Tyr stabilizes Y--a new, composite quaternary state of human hemoglobin.</PubMed_Title>
      <Author>Smith FR, et al.</Author>
      <Journal>Proteins.1991;10(2):81-91.</Journal>
      <PubMed_ID>1896430</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaW37E OXY (10 test sets)</PDB_Title>
      <PDB_ID>1YEV</PDB_ID>
      <Resolution>2.11</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YEV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE 1.8 ANGSTROM STRUCTURE OF CARBONMONOXY-BETA4 HEMOGLOBIN: ANALYSIS OF A HOMOTETRAMER WITH THE R QUATERNARY STRUCTURE OF LIGANDED ALPHA2BETA2 HEMOGLOBIN</PDB_Title>
      <PDB_ID>1CBM</PDB_ID>
      <Resolution>1.74</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CBM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>The 1.8 A structure of carbonmonoxy-beta 4 hemoglobin. Analysis of a homotetramer with the R quaternary structure of liganded alpha 2 beta 2 hemoglobin.</PubMed_Title>
      <Author>Borgstahl GE, et al.</Author>
      <Journal>J Mol Biol.1994 Feb 25;236(3):817-30.</Journal>
      <PubMed_ID>8114096</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystallographic Analysis of the Interaction of Nitric Oxide with Quaternary-T Human Hemoglobin. Hemoglobin exposed to NO under anerobic conditions</PDB_Title>
      <PDB_ID>1RPS</PDB_ID>
      <Resolution>2.11</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1RPS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$NITRIC OXIDE</Ligand_Name>
      <PubMed_Title>Crystallographic analysis of the interaction of nitric oxide with quaternary-T human hemoglobin.</PubMed_Title>
      <Author>Chan NL, et al.</Author>
      <Journal>Biochemistry.2004 Jan 13;43(1):118-32.</Journal>
      <PubMed_ID>14705937</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of liganded hemoglobin in complex with a potent antisickling agent, INN-266</PDB_Title>
      <PDB_ID>3IC2</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3IC2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>4-[(5-methoxy-2-methylphenoxy)methyl]pyridine$PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE$SULFATE ION</Ligand_Name>
      <PubMed_Title>Structural and in Vitro Chracterization of Pyridyl Derivatives of Benzaldehydes: Highly Potent Antisickling Agents</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: betaN108A deoxy low-salt (1 test set)</PDB_Title>
      <PDB_ID>1Y7Z</PDB_ID>
      <Resolution>1.98</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y7Z</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Direct observation of photolysis-induced tertiary structural changes in human haemoglobin; Crystal structure of alpha(Fe-CO)-beta(Ni) hemoglobin (laser unphotolysed)</PDB_Title>
      <PDB_ID>1J3Z</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J3Z</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>BUT-2-ENEDIAL$CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$PROTOPORPHYRIN IX CONTAINING NI(II)</Ligand_Name>
      <PubMed_Title>Direct observation of photolysis-induced tertiary structural changes in hemoglobin</PubMed_Title>
      <Author>Adachi S, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A.2003 Jun 10;100(12):7039-44. Epub  2003 May 28.</Journal>
      <PubMed_ID>12773618</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-to-THigh Quaternary Transitions in Human Hemoglobin: desArg141alpha deoxy low-salt</PDB_Title>
      <PDB_ID>1Y0D</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y0D</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
    </PDB>
    <PDB>
      <PDB_Title>T-to-THigh Quaternary Transitions in Human Hemoglobin: alphaL91A deoxy low-salt</PDB_Title>
      <PDB_ID>1XZ5</PDB_ID>
      <Resolution>2.11</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XZ5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A novel quaternary structure of human carbonmonoxy hemoglobin</PDB_Title>
      <PDB_ID>1YZI</PDB_ID>
      <Resolution>2.07</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YZI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CARBON MONOXIDE$PROTOPORPHYRIN IX CONTAINING FE$TOLUENE</Ligand_Name>
      <PubMed_Title>The enigma of the liganded hemoglobin end state: a novel quaternary structure of human carbonmonoxy hemoglobin.</PubMed_Title>
      <Author>Safo MK, et al.</Author>
      <Journal>Biochemistry.2005 Jun 14;44(23):8347-59.</Journal>
      <PubMed_ID>15938624</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: desHIS146beta deoxy low-salt</PDB_Title>
      <PDB_ID>1Y85</PDB_ID>
      <Resolution>2.13</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Y85</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>ANALYSIS OF THE CRYSTAL STRUCTURE, MOLECULAR MODELING AND INFRARED SPECTROSCOPY OF THE DISTAL BETA-HEME POCKET VALINE67(E11)-THREONINE MUTATION OF HEMOGLOBIN</PDB_Title>
      <PDB_ID>1HDB</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HDB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$SULFATE ION</Ligand_Name>
      <PubMed_Title>Crystallographic, molecular modeling, and biophysical characterization of the valine beta 67 (E11)--&gt;threonine variant of hemoglobin.</PubMed_Title>
      <Author>Pechik I, et al.</Author>
      <Journal>Biochemistry.1996 Feb 13;35(6):1935-45.</Journal>
      <PubMed_ID>8639677</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-to-THigh Transitions in Human Hemoglobin: alphaK40G deoxy low-salt</PDB_Title>
      <PDB_ID>1XY0</PDB_ID>
      <Resolution>1.99</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XY0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN DEOXYHAEMOGLOBIN-2,3-DIPHOSPHOGLYCERATE COMPLEX</PDB_Title>
      <PDB_ID>1B86</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1B86</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03910075</ASD_Ligand>
      <Ligand_Name>[7,12-DEACETYL-3,8,13,17-TETRAMETHYL-21H,23H- PORPHINE-2,18-DIPROPANOATO(2-)
-N21,N22,N23,N24]- IRON$2,3-DIPHOSPHOGLYCERIC ACID$PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Human deoxyhaemoglobin-2,3-diphosphoglycerate complex low-salt structure at 2.5 A resolution.</PubMed_Title>
      <Author>Richard V, et al.</Author>
      <Journal>J Mol Biol.1993 Sep 20;233(2):270-4.</Journal>
      <PubMed_ID>8377203</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>T-To-T(High) quaternary transitions in human hemoglobin: HbA OXY (10.0MM IHP, 20% PEG) (10 test sets)</PDB_Title>
      <PDB_ID>1YHR</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1YHR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PROTOPORPHYRIN IX CONTAINING FE$OXYGEN MOLECULE</Ligand_Name>
      <PubMed_Title>Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.</PubMed_Title>
      <Author>Kavanaugh JS, et al.</Author>
      <Journal>Biochemistry.2005 Apr 26;44(16):6101-21.</Journal>
      <PubMed_ID>15835899</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05143</Pathway_ID>
      <Pathway_Title>African trypanosomiasis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05144</Pathway_ID>
      <Pathway_Title>Malaria</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All alpha proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.b.b.b.d.bi.html</SCOP_URL>
    <CATH_Class>Mainly alpha</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1a01</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,105,Arg;site,109,Asn;site,36,Tyr;site,102,Glu</Site_Detail>
      <Site_Reference>Abraham DJ, et al. Biochemistry. 1992,31(38):9141-9149.;Yokoyama T, et al. J Mol Biol. 2006,356(3):790-801.</Site_Reference>
      <Site_Type>Nested subunit-subunit interactions</Site_Type>
      <PDB_ID>2D5Z;2D60;1B86</PDB_ID>
      <PubMed_ID>1390701;16403522</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Allosteric_Pathway>
    <Method>Mutations</Method>
    <Verified__Residue>V54, K66, L96, D99, P100, N102, F103</Verified__Residue>
    <PubMed_Title>Suel GM, et al. Nat Struct Biol. 2003,10(1):59-69.@@Arous N, et al. FEBS Lett. 1981,126(1):114-116.@@Tamagnini GP, et al. Hemoglobin. 1991,15(6):487-496.@@Lacan P, et al. Am J Hematol. 1996,51(4):276-281.</PubMed_Title>
    <PubMed_ID>12483203@@7238856@@1814856@@8602627</PubMed_ID>
    <is__ref__img>No</is__ref__img>
    <is__display>No</is__display>
    <in__pathway__browse>No</in__pathway__browse>
  </Allosteric_Pathway>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00150001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01330001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03710001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910002</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910003</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910004</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910005</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910006</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910007</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910008</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910009</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910010</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910011</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910012</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910013</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910014</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910015</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910016</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910017</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910018</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910019</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910020</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910021</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910022</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910023</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910024</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910025</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910026</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910027</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910028</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910029</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910030</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910031</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910032</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910033</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910034</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910035</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910036</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910037</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910038</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910039</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910040</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910041</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910042</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910043</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910044</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910045</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910046</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910047</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910048</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910049</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910050</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910051</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910052</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910053</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910054</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910055</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910056</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910057</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910058</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910059</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910060</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910061</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910062</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910063</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910064</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910065</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910066</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910067</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910068</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910069</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910070</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910071</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910072</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910073</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910075</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910077</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910078</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910079</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910080</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910081</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910082</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910083</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910084</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910085</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910086</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910087</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910088</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910089</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910090</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910091</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910092</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910093</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910094</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910095</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910096</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910097</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910099</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910100</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910101</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910102</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910103</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910104</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910105</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910106</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910107</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910108</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910109</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910110</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910111</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910112</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910113</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910114</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910115</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910116</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910117</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910118</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910119</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910120</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03910121</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03911001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912004</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912005</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912008</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912010</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912012</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912013</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912014</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912015</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912016</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912017</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912018</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912029</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912031</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912033</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912035</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912037</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912039</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912041</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912043</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912044</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912045</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912046</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912047</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912048</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912049</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912050</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912051</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912052</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912077</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03912078</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03918001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD08650001</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>